Enzon Pharmaceuticals, Inc.

Revision as of 22:05, 19 August 2022 by 95.149.241.133 (talk)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Summary

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.